Related Experiment Video
Updated: Mar 6, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
[Myocardial Revascularization in Patients With Chronic Ischemic Heart Disease Combined With Chronic Obstructive
V K Zafiraki1, K V Skaletsky1, E D Kosmacheva1
11Kuban State Medical University, Krasnodar, Russia; 2Central Hospital of Oilworkers, Baku, Azerbaijan; 3Scientific and Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
Insights
Chronic obstructive pulmonary disease (COPD) significantly impacts coronary artery disease prognosis and outcomes after myocardial revascularization procedures. This review analyzes studies assessing COPD's effect on surgical and interventional cardiac treatments.
Area of Science:
- Cardiology
- Pulmonology
- Clinical Outcomes Research
Background:
- Coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) are prevalent conditions.
- COPD is increasingly recognized as a significant comorbidity in patients with CAD.
- The impact of COPD on cardiac procedures requires thorough investigation.
Purpose of the Study:
- To review and analyze existing studies evaluating COPD as a prognostic factor in patients undergoing myocardial revascularization.
- To assess the influence of COPD on perioperative risks and long-term outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary interventions (PCI).
Main Methods:
- Systematic review of literature.
- Analysis of studies investigating the association between COPD and outcomes of myocardial revascularization.
- Examination of perioperative complications and long-term results.
Main Results:
- Accumulated data suggests COPD is a key factor in poor prognosis for CAD patients.
- COPD may increase perioperative risks associated with CABG and PCI.
- The presence of COPD can negatively affect long-term outcomes following revascularization procedures.
Conclusions:
- COPD significantly influences the prognosis of patients with coronary artery disease.
- Understanding COPD's impact is crucial for managing patients undergoing myocardial revascularization.
- Further research is warranted to optimize perioperative and long-term care for these patients.
Abstract:
Currently enough data has been accumulated to consider chronic obstructive pulmonary disease (COPD) as one of important factors of poor prognosis in patients with coronary artery disease, possibly producing an impact on perioperative risk during coronary artery bypass grafting surgery and percutaneous coronary interventions, as well as on long-term outcomes of these procedures. In this review we have analyzed studies which attempted to assess COPD as a factor that can affect outcomes of myocardial revascularization.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

